2nd Quarter - Report — COREWELL HEALTH for COREWELL HEALTH (2021)

Firm

COREWELL HEALTH

Client

COREWELL HEALTH

Income

—

Expenses

$50,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions on Risk Adjustment. Discussions on Telehealth Access and Reimbursement. Discussions about decreasing vaccine hesitancy. Discussions on Pediatric and Adult Behavioral Health Crisis. Discussions about non-discriminatory and equitable blood donations.

Lobbyist	Covered position, as disclosed
DAVID BILARDELLO	—
PHILIP D YEITER	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Medicare/Medicaid MMM

Discussions on Risk Adjustment. Discussions on Telehealth Access and Reimbursement. Discussions about decreasing vaccine hesitancy. Discussions on Pediatric and Adult Behavioral Health Crisis.

Lobbyist	Covered position, as disclosed
DAVID BILARDELLO	—
PHILIP D YEITER	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.